766 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
ABBV AbbVie Inc. $95.37 $144.42B N/A
Article Searches
Value Biotech ETFs & Stocks to Buy Now http://www.zacks.com/stock/news/602866/value-biotech-etfs-stocks-to-buy-now?cid=CS-ZC-FT-etf_news_and_commentary-602866 Nov 04, 2019 - Biotech valuation looks attractive amid a volley of good news. Investors can tap these stocks and ETFs.
Top Ranked Income Stocks to Buy for November 4th http://www.zacks.com/commentary/602519/top-ranked-income-stocks-to-buy-for-november-4th?cid=CS-ZC-FT-zacks_#1_rank_additions-602519 Nov 04, 2019 - Top Ranked Income Stocks to Buy for November 4th
Novo Nordisk (NVO) Q3 Earnings Beat Estimates, Revenues Miss http://www.zacks.com/stock/news/602358/novo-nordisk-nvo-q3-earnings-beat-estimates-revenues-miss?cid=CS-ZC-FT-analyst_blog|earnings_article-602358 Nov 04, 2019 - Novo Nordisk (NVO) beats earnings estimates but misses sales estimates in the third quarter of 2019.
AbbVie Inc. (ABBV) CEO Rick Gonzalez on Q3 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4301605-abbvie-inc-abbv-ceo-rick-gonzalez-q3-2019-results-earnings-call-transcript?source=feed_sector_healthcare Nov 01, 2019 - AbbVie Inc. (NYSE:ABBV) Q3 2019 Earnings Conference Call November 1, 2019 9:00 AM ET Company Participants Liz Shea - Vice President of Investor Relations Rick Gonzalez - Chairman & Chief Executive
AbbVie Inc (ABBV) Q3 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/11/01/abbvie-inc-abbv-q3-2019-earnings-call-transcript.aspx?source=iedfolrf0000001 Nov 01, 2019 - ABBV earnings call for the period ending September 30, 2019.
WIll Allergan (AGN) Beat Estimates This Earnings Season? http://www.zacks.com/stock/news/598369/will-allergan-agn-beat-estimates-this-earnings-season?cid=CS-ZC-FT-analyst_blog|earnings_preview-598369 Nov 01, 2019 - Allergan's (AGN) key products like Botox are likely to have provided top-line support in Q3 as loss of exclusivity of several products hurts sales.
Pharma Stock Roundup: MRK, PFE, GSK, BMY Q3 Earnings, Other Updates http://www.zacks.com/stock/news/598340/pharma-stock-roundup-mrk-pfe-gsk-bmy-q3-earnings-other-updates?cid=CS-ZC-FT-analyst_blog|stock_roundup-598340 Nov 01, 2019 - Pfizer (PFE), Merck (MRK), Bristol-Myers (BMY) and others release Q3 results.
Top Ranked Growth Stocks to Buy for November 1st http://www.zacks.com/commentary/598087/top-ranked-growth-stocks-to-buy-for-november-1st?cid=CS-ZC-FT-zacks_#1_rank_additions-598087 Nov 01, 2019 - Top Ranked Growth Stocks to Buy for November 1st
AbbVie (ABBV) Q3 Earnings and Revenues Beat Estimates http://www.zacks.com/stock/news/597997/abbvie-abbv-q3-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-597997 Nov 01, 2019 - AbbVie (ABBV) delivered earnings and revenue surprises of 1.75% and 0.80%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Why AbbVie (ABBV) is a Great Dividend Stock Right Now http://www.zacks.com/stock/news/592443/why-abbvie-abbv-is-a-great-dividend-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_5-592443 Oct 30, 2019 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.

Pages: 1234567...77

<Page 2>